FP
Flagship Pioneering Portfolio holdings
AUM
$268M
This Quarter Return
-24.86%
1 Year Return
-54.4%
3 Year Return
-51.2%
5 Year Return
+66.7%
10 Year Return
–
AUM
$2.05B
AUM Growth
+$2.05B
(+35%)
Cap. Flow
+$898M
Cap. Flow
% of AUM
43.86%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
–
Reduced
–
Closed
–
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Moderna
MRNA
$9.37B
| $898M | 43.86% |
+58,807,379
| New | +$898M |
|
|
RUBY
2
DELISTED
Rubius Therapeutics, Inc
RUBY
| $616M | 30.07% |
38,296,526
| – | – |
|
|
EVLO
3
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $237M | 11.58% |
18,233,403
| – | – |
|
4
Denali Therapeutics
DNLI
$2.23B
| $184M | 9% |
8,918,749
| – | – |
|
5
Seres Therapeutics
MCRB
$166M
| $57.3M | 2.8% |
12,682,876
| – | – |
|
6
Quanterix
QTRX
$211M
| $37.2M | 1.82% |
2,030,495
| – | – |
|
|
SYRS
7
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $17.8M | 0.87% |
3,204,437
| – | – |
|